Characterized Starting Materials for Accelerated and Scalable Allogeneic Cell Therapies

Time: 10:30 am
day: Day One


  • Leveraging access to highly annotated diseased biomaterials for enhanced target discovery
  • Outline how characterized donor source materials can impact consistency from process development to manufacturing
  • Incorporating multiomic analytics of the cell-based starting materials to enhance downstream processing